Fenibut-Astrafarm is a psychogogic and nootropic means. Indications

• asthenic it is also disturbing neurotic states (emotional lability, a memory impairment, decrease in concentration of attention), concern, fear, uneasiness, neurosis of persuasive states;
• at children of 8 years – stutter, enuresis, tics;
• at patients of advanced age – insomnia, night concern;
• prevention of stressful states before operations or painful diagnostic tests;
• Menyer's disease, the dizziness connected with dysfunction of a vestibular mechanism, motion desease prevention;
• as supportive application at treatment of an abstinence syndrome at alcoholism.

Structure

• 1 tablet contains Phenibutum of 250 mg;
• other components: lactose, monohydrate; potato starch; calcium stearate.

Contraindication

Hypersensitivity to medicine components.

Acute renal failure.

Route of administration

Fenibut-Astrafarm is accepted inside before food.

At asthenic and alarming and neurotic states are appointed on 250-500 mg by 3 times a day. The highest single dose for adults – 750 mg, for patients of advanced age – 500 mg.

Course of treatment makes 2-3 weeks. If necessary the course of treatment can be increased up to 4-6 weeks.

to Children of 8 years – on 250 mg 3 times a day, to children of 14 years – doses for adults.

In the dizziness connected with dysfunction of a vestibular mechanism of infectious genesis and at Menyer's disease medicine are appointed on 750 mg by 3 times a day within 5-7 days, at reduction of expressiveness of vestibular frustration – on 250-500 mg 3 times a day within 5-7 days, then on 250 mg of 1 times a day within 5 days. At rather easy course of diseases of Fenibut-Astrafarm apply 250 mg 2 times a day within 5-7 days, and then on 250 mg within 7-10 days once a day.

Feature of application

patients Should be careful with pathology of a digestive tract because of Phenibutum irritant action. Such patients should appoint smaller doses. At long application it is necessary to control cellular composition of blood, indicators of function of a liver.

by

as there are no sufficient data on use of medicine during these periods.

Children

children can use Drug of 8 years.

Drivers

to Patients at whom during medicament treatment arise drowsiness, dizziness or other reactions from central nervous system should abstain from control of vehicles or work with other mechanisms.

Overdose

Symptoms: drowsiness, nausea, vomiting, possible development of arterial hypotension, OPN.

Side effects

from nervous system: drowsiness (in an initiation of treatment), a headache and dizziness (in doses it is higher than 2 g/days, at reduction of a dose the expressiveness of side effect decreases).

from a digestive tract: nausea (in an initiation of treatment), vomiting, diarrhea, pains in epigastric area.

from a gepatobiliarny system: hepatotoxicity (at long application of high doses).

from the immune system: allergic reactions, including rash, an itch, urticaria, erubescence.

to Store

in original packing at a temperature not above 25 °C.

to Store

out of children's reach.